Current Role and Company Affiliation
Emily Rymland, DNP, FNP-C, AAHIVS currently serves as the Los Angeles Market Medical Director at Tia, a women’s health company headquartered in Santa Monica, CA. She is also identified as part of Tia's clinical leadership team focused on reinventing women's healthcare. Her role involves overseeing clinical operations and contributing expertise toward integrating comprehensive care models at Tia.
Professional Experience and Specialization
Emily Rymland has dedicated over 30 years to the medical field, with a concentrated focus on HIV care and prevention within the United States. Her career began during the height of the AIDS epidemic, which shaped her clinical interests and specialization. She is an AAHIVS-certified HIV specialist and a Family Nurse Practitioner with extensive experience in sexual, transgender, and HIV medical advisement via telehealth platforms.
Before her tenure at Tia, she held leadership and clinical roles such as:
- Director of Clinical Operations at Nurx (a telehealth company specializing in sexual health)
- Former Medical Director and Board Member at Buseesa Community Development Centre
- Nurse Practitioner at East Bay AIDS Center in Oakland, California
- Clinical work involving women's health at Planned Parenthood
Emily has managed clinical teams and programs broadly targeted at underserved populations, including rural communities, evidenced by her medical directorship at Em’s Clinic in Uganda. Her career highlights a consistent integration of primary care, women’s health, and HIV specialty services.
Education and Credentials
- Doctor of Nursing Practice (DNP)
- Family Nurse Practitioner (FNP-C) certification
- Education includes programs at University of Massachusetts Amherst, University of California Davis School of Nursing, and certification by the American Academy of Nurse Practitioners (certified since 2007).
- Certified HIV Specialist through the American Academy of HIV Medicine (AAHIVS)
Thought Leadership and Public Advocacy
Emily Rymland contributes to thought leadership in HIV and women’s health, evidenced by authorship of expert articles such as “On the Cusp of Breakthroughs in HIV Medicine” through the American Academy of HIV Medicine and commentary on telehealth’s role in overcoming care barriers. She is actively engaged in public discourse on healthcare equity, particularly women’s health, exemplified by her advocacy for reducing out-of-pocket healthcare costs for women’s products and addressing systemic healthcare inequities.
She has also participated in formal advocacy communications dated February 2025 related to women's health policy.
Relevant Publications and Media Presence
Though detailed publication records are limited, she has been featured in:
- Articles for Nurx and the American Academy of HIV Medicine
- Written reflections and advocacy posts on LinkedIn and Medium focusing on challenges in women’s health and chronic conditions affecting women
- Media engagement through InsideSources on healthcare during the COVID-19 pandemic
Operational and Telehealth Expertise
Emily’s recent work includes leadership in telehealth services, managing nursing and clinical advisory roles focused on sexual health, transgender health, and HIV medicine at Nurx and Tia. Her credentials and extensive experience highlight her capability to drive telemedicine strategies, improve patient access, and influence clinical program development within these domains.
Summary: Emily Rymland is a seasoned healthcare leader at Tia specializing in HIV care, women’s health, and telehealth clinical operations. Her multi-decade experience and advanced credentials qualify her as an expert collaborator on integrated care models and healthcare access initiatives, supporting Tia’s mission to transform women’s health services with an emphasis on equity and innovation.
